Rite Aid (RAD) surges 30% higher as merger chances improve >>> READ MORE


5 Healthcare Stocks Poised to Trump Q3 Earnings

Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat More 

3 Big Pharma Stocks That Are Looking a Little Pale

These Big Pharma stocks need to justify their big price tags after disappointing results: Bristol-Myers (BMY), Merck (MRK) and Eli Lilly (LLY). More 

BMY Stock: Don’t Try to Catch This Falling Knife … Yet

Bristol-Myers (BMY) stock is a hot mess right now, but it still has long-term value in its cancer drug pipeline. More 

Tuesday’s Vital Data: Apple Inc. (AAPL), Twitter Inc (TWTR) and Bristol-Myers Squibb Co (BMY)

A bid in Apple shares and strength from the energy complex put the NASDAQ back near all-time-highs, while TWTR and BMY are under pressure. More 

Why Twitter Inc (TWTR), Bristol-Myers Squibb Co (BMY) and Twilio Inc (TWLO) Are 3 of Today’s Worst Stocks

Twitter (TWTR), Bristol-Myers Squibb (BMY) and Twilio (TWLO) each uses more than their fair share of red ink on Monday. More 

Bristol-Myers Squibb Co (BMY) Suffers Heavy Dose of Disappointment

BMY stock -- at around $49 -- is now fairly valued. But given its failure rate, waiting for Bristol-Myers to get to "cheap" is the best bet before buying. More 

3 Stocks to Watch Monday: Mylan NV (MYL), Bristol-Myers Squibb Co (BMY) and Comcast Corporation (CMCSA)

Mylan (MYL) is bouncing back to life on an Epipen settlement, Bristol-Myers Squibb (BMY) is getting hit again on Opdivo disappointment and everyone still hates Comcast (CMCSA). More